July 4 (Reuters) - Bpifrance Executive Director Jose Gonzalo said that the public investment bank is considering a potential investment in Sanofi's (SASY.PA), opens new tab consumer health unit, Bloomberg News reported on Thursday.
France Might Block Drugmaker Biogaran’s Sale to Foreign Firm
An Indian industrialist wants to buy Biogaran, the French number one in generics
Since winter 2022, drug shortages have increased, such as Amoxicillin, the most prescribed antibiotic in France
Biogaran participates in a screening operation for hypertension and diabetes in Benin
French generic medicine manufacturer, Biogaran has announced the acquisition of Nigeria’s Swiss Pharmaceutical company (Swipha) under a deal that would see the new owners intensifying local production of drugs in the country.